Altimmune Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Altimmune, Inc. (ALT)

3.505 -0.74 (-17.53%) USD | NASDAQ | Mar 05, 16:00

3.64 +0.14 (+3.85%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for ALT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Eli Lilly & Co.	Upgrade
Viking Therapeutics, Inc.	Upgrade
CorMedix, Inc.	Upgrade
Actinium Pharmaceuticals, Inc.	Upgrade